Jef Williams[email protected]IS5 steps to improve your imaging IT strategyAre you doing all you can to implement an effective imaging IT strategy? In a new column, Jef Williams of Paragon Consulting Partners discusses five steps you can take to make sure you're prepared for the emerging healthcare landscape.June 8, 2016PACS/VNAReversing for success -- universal viewers and VNAsMuch has been written and spoken about vendor-neutral archiving (VNA) and its trailing associated technology, the universal viewer. But do you really need to wait until the VNA is installed before adopting a universal viewer? Maybe not, according to Jef Williams of Ascendian Healthcare Consulting.June 2, 2013PACS/VNAImaging Interoperability: Part 2 -- The 3 flavors of VNAAuntMinnie.com presents the second in a two-part series on imaging interoperability from Jonathan Shoemaker and Jef Williams of Ascendian Healthcare Consulting. In Part 2, the authors present the key factors that best leverage the functionality of a true VNA.March 14, 2013PACS/VNAImaging Interoperability: Part 1 -- New optionsAuntMinnie.com presents the first in a two-part series from Jonathan Shoemaker and Jef Williams of Ascendian Healthcare Consulting. In part 1, the authors explain how vendor-neutral archives can provide much-needed interoperability in today's tumultuous healthcare environment.September 6, 2012Page 1 of 1Top StoriesCTCT muscle metrics could help screen for sarcopeniaAbdominal CT muscle metrics taken from imaging of healthy young people show promise for opportunistic sarcopenia screening.Womens ImagingCancer incidence on rise in younger people, womenAssociationsFinancial shock waves strike close to radiology researchersMRICNN techniques outperform conventional DL for Alzheimer's diagnosisWomens ImagingAbout half of women undecided on AI's use in breast imaging
![Images depict axial MRI scans in a 50-year-old premenopausal female patient with biopsy-proven 12-mm invasive lobular cancer in the lower outer quadrant of the left breast. Upper images are subtracted dynamic contrast-enhanced (DCE) MRI scans from the first and second postcontrast acquisitions. Lower images are ultrafast MRI scans obtained within 24 hours after the DCE study (four consecutive subtracted dynamic frames from time points [T] 6–9). There is marked background parenchymal enhancement (BPE) on the DCE MRI scans. Thus, the known cancer (arrow) is barely visible; it exhibits only slightly stronger enhancement than the normal fibroglandular tissue, which results in low conspicuity. At ultrafast MRI there is less BPE, and still the cancer is barely visible because it starts to enhance simultaneously with the BPE. The conspicuity of the cancer is even reduced compared with the DCE series. Both of the readers missed this cancer on both the DCE and ultrafast MRI scans.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2025/05/2025-05-06-rsna-ultrafast-dce-mri-breast.Gzvq76udFr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
